Subcutenous xenografts of human t-lineage acute lymphoblastic leukemia jurkat cells in nude mice

In Vivo

Volumn 25, Issue 4, 2011, Pages 603-607

  Mezencev, Roman ^a   Mcdonald, John F ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Jurkat cells; Leukemia; Lymphoblastic lymphoma; Nude mice; T acute lymphoblastic leukemia; Tumor xenograft

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HISTOPATHOLOGY; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; T ACUTE LYMPHOBLASTIC LEUKEMIA; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 79960634945     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Uckun FM, Sensel MG, Sun L, Steinherz PG, Trigg ME, Heerema NA, Sather HN, Reaman GH and Gaynon PS: Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood 91(5): 735-746, 1998. (Pubitemid 28078273)
2. Schneider U, Schwenk HU and Bornkamm G: Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 79(5): 621-626, 1977.
3. Chiarini F, Grimaldi C, Ricci F, Tazzari PL, Evangelisti C, Ognibene A, Battistelli M, Falcieri E, Melchionda F, Pession A, Pagliaro P, McCubrey JA and Martelli AM: Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia. Cancer Res 70(20): 8097-8107, 2010.
4. Youns M, Fu YJ, Zu YG, Kramer A, Konkimalla VB, Radlwimmer B, Sültmann H and Efferth T: Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T-cell acute lymphoblastic leukaemia cell lines by pharmacogenomics. Naunyn Schmiedebergs Arch Pharmacol 582(5): 221-234, 2010.
5. Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez Cara C, Carrion MD, Brancale A, Hamel E, Chen L, Bortolozzi R, Basso G and Viola G: Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. J Med Chem 55(70): 4248-4258, 2010.
6. dos Santos MP, Schwartsmann G, Roesler R, Brunetto AL and Abujamra AL: Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells. Leuk Res 33(2): 218-221, 2009.
7. Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J, Jia S, Herich J, Labreque D, Storer R, Meerovitch K, Bouffard D, Rej R, Denis R, Blais C, Lamothe S, Attardo G, Gourdeau H, Tseng B, Kasibhatla S and Cai SX: Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. J Med Chem 47(25): 6299-6310, 2004.
8. Townsend JB, Shaheen F, Liu R and Lam KS: Jeffamine derivatized TentaGel beads and poly(dimethylsiloxane) microbead cassettes for ultrahigh-throughput in situ releasable solution-phase cell-based screening of one-bead-one-compound combinatorial small molecule libraries. J Comb Chem 12(5): 700-712, 2010.
9. Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornman W, Finn R, Akhurst T, Larson S, Blasberg R, Sadelain M and Tjuvajev JG: Imaging TCR-dependent NFAT-mediated T-cell activation with positron-emission tomography in vivo. Neoplasia 3(6): 480-488, 2001. (Pubitemid 33151014)
10. Neville DM Jr, Scharff J and Srinivasachar K: In vivo T-cell ablation by a holo-immunotoxin directed at human CD3. Proc Natl Acad Sci USA 89(7): 2585-2589, 1992.
11. Fujita K, Tsujimura A, Hirai T, Ohta H, Matsuoka Y, Miyagawa Y, Takao T, Takada S, Nonomura N and Okuyama A: Effect of human leukemia cells in testicular tissues grafted into immunodeficient mice. Int J Urol 75(8): 733-738, 2008.
12. 2 checkpoint. J Antibiot (Tokyo) 57(70): 662-668, 2004. (Pubitemid 39472817)
13. Norton L and Simon R: New thoughts on the relationship of tumor growth characteristics to sensitivity to treatment. In: Methods in Cancer Research. Vol. XVII, Part B. DeVita V and Busch H (eds.) Academic Press, New York, pp. 53-90, 1979.
14. Ullman-Culleré MH and Foltz CJ: Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci 49(3): 319-323, 1999. (Pubitemid 29284390)
15. Waurzyniak B, Schneider EA, Turner N, Yanishevski Y, Gunther R, Chelstrom LM, Wendorf H, Myers DE, Irvin JD, Messinger Y, Ek O, Zeren T, Langlie MC, Evans WE and Uckun FM: In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin. Clin Cancer Res 3(6): 881-890, 1997.
16. Plowman J, Dykes DJ, Hollingshead M, Simpson-Herren L and Alley MC: Human tumor xenograft models in NCI drug development. In: Anticancer Drug Development Guide. Teicher BA (ed.). Humana Press, Totowa, NJ, pp. 101-125, 1997.
17. Topley P, Jenkins DC, Jessup EA and Stables JN: Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice. Br J Cancer 67(5): 953-958, 1993. (Pubitemid 23147485)
18. Corbett T, LoRusso P, Panchapor C, White K, Demchik L and Jones L: In vivo methods for screening and preclinical testing. In: Anticancer Drug Development Guide. Teicher BA (ed.). Humana Press, Totowa, NJ, pp. 75-99, 1997.